Robert Janssen - Feb 10, 2025 Form 4 Insider Report for DYNAVAX TECHNOLOGIES CORP (DVAX)

Role
SVP and CMO
Signature
/s/ Robert Janssen
Stock symbol
DVAX
Transactions as of
Feb 10, 2025
Transactions value $
-$23,509
Form type
4
Date filed
2/12/2025, 04:57 PM
Previous filing
Feb 20, 2024
Next filing
Feb 18, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DVAX Common Stock Options Exercise +4.33K +7.38% 63K Feb 10, 2025 Direct F1
transaction DVAX Common Stock Tax liability -$23.5K -1.78K -2.83% $13.20 61.2K Feb 10, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DVAX Restricted Stock Unit Options Exercise -4.33K -100% 0 Feb 10, 2025 Common Stock 4.33K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 10, 2022.
F2 Shares withheld by Dynavax Technologies Corporation to satisfy tax withholding requirements on vesting of restricted stock units.